Replies to post #311932 on Innovation Pharmaceuticals Inc (IPIX)

[djs7]

I would like to see several dosing regimens per each active Brilacidin treatment arm. Leave out the mild cases.
Moderate-Severe-Critical (5:3:1 ratio) in each active treatment arm.